Correlation between mRNAseq expression and clinical features
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (Primary solid tumor)
17 October 2014  |  analyses__2014_10_17
Maintainer Information
Citation Information
doi:10.7908/C1GT5M01
Maintained by Juok Cho (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): Correlation between mRNAseq expression and clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C1GT5M01
Overview
Introduction

This pipeline uses various statistical tests to identify mRNAs whose log2 expression levels correlated to selected clinical features.

Summary

Testing the association between 18197 genes and 45 clinical features across 239 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 16 clinical features related to at least one genes.

  • 13 genes correlated to 'Time to Death'.

    • TM2D1|83941 ,  GATS|352954 ,  ZER1|10444 ,  EGLN1|54583 ,  PEAR1|375033 ,  ...

  • 41 genes correlated to 'AGE'.

    • NXNL2|158046 ,  RHOF|54509 ,  LANCL1|10314 ,  RARB|5915 ,  DBI|1622 ,  ...

  • 1 gene correlated to 'PATHOLOGY.N.STAGE'.

    • ART3|419

  • 1908 genes correlated to 'HISTOLOGICAL.TYPE'.

    • EPCAM|4072 ,  TP63|8626 ,  GPR109A|338442 ,  BICD2|23299 ,  GM2A|2760 ,  ...

  • 2 genes correlated to 'NUMBER.OF.LYMPH.NODES'.

    • CD99L2|83692 ,  ART3|419

  • 2 genes correlated to 'RACE'.

    • XKR9|389668 ,  RNF112|7732

  • 5 genes correlated to 'WEIGHT_KG_AT_DIAGNOSIS'.

    • HCG26|352961 ,  AGER|177 ,  NUBP1|4682 ,  AKAP5|9495 ,  BLOC1S1|2647

  • 4 genes correlated to 'NEOPLASMHISTOLOGICGRADE'.

    • ABLIM1|3983 ,  CDS1|1040 ,  FUT6|2528 ,  FUT2|2524

  • 1 gene correlated to 'TOBACCO_SMOKING_HISTORY'.

    • GPR15|2838

  • 4 genes correlated to 'MENOPAUSE_STATUS'.

    • SSBP3|23648 ,  RARB|5915 ,  DBI|1622 ,  PRSS23|11098

  • 2 genes correlated to 'LYMPH_NODES_EXAMINED_HE_COUNT'.

    • CD99L2|83692 ,  ART3|419

  • 1 gene correlated to 'KERATINIZATION_SQUAMOUS_CELL'.

    • QKI|9444

  • 1 gene correlated to 'INITIAL_PATHOLOGIC_DX_YEAR'.

    • C9ORF171|389799

  • 7 genes correlated to 'CERVIX_SUV_RESULTS'.

    • C14ORF33|100129075 ,  C7ORF11|136647 ,  ELFN2|114794 ,  GRK7|131890 ,  HAMP|57817 ,  ...

  • 1 gene correlated to 'AJCC_TUMOR_PATHOLOGIC_PT'.

    • FBXL18|80028

  • 38 genes correlated to 'AGE_AT_DIAGNOSIS'.

    • NXNL2|158046 ,  DBI|1622 ,  GPR97|222487 ,  UBASH3B|84959 ,  PGR|5241 ,  ...

  • No genes correlated to 'PATHOLOGY.T.STAGE', 'PATHOLOGY.M.STAGE', 'RADIATIONS.RADIATION.REGIMENINDICATION', 'NUMBERPACKYEARSSMOKED', 'ETHNICITY', 'TUMOR_STATUS', 'TUMOR_SAMPLE_PROCUREMENT_COUNTRY', 'TOBACCO_SMOKING_YEAR_STOPPED', 'TOBACCO_SMOKING_PACK_YEARS_SMOKED', 'PATIENT.AGEBEGANSMOKINGINYEARS', 'RADIATION_TOTAL_DOSE', 'RADIATION_THERAPY_TYPE', 'RADIATION_THERAPY_STATUS', 'RADIATION_THERAPY_SITE', 'RADIATION_ADJUVANT_UNITS', 'PREGNANCIES_COUNT_TOTAL', 'PREGNANCIES_COUNT_STILLBIRTH', 'PATIENT.PATIENTPREGNANCYSPONTANEOUSABORTIONCOUNT', 'PREGNANCIES_COUNT_LIVE_BIRTH', 'PATIENT.PATIENTPREGNANCYTHERAPEUTICABORTIONCOUNT', 'PREGNANCIES_COUNT_ECTOPIC', 'POS_LYMPH_NODE_LOCATION', 'LYMPHOVASCULAR_INVOLVEMENT', 'LYMPH_NODES_EXAMINED', 'HISTORY_HORMONAL_CONTRACEPTIVES_USE', 'HEIGHT_CM_AT_DIAGNOSIS', 'CORPUS_INVOLVEMENT', 'CHEMO_CONCURRENT_TYPE', and 'STAGE_EVENT.CLINICAL_STAGE'.

Results
Overview of the results

Complete statistical result table is provided in Supplement Table 1

Table 1.  Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.

Clinical feature Statistical test Significant genes Associated with                 Associated with
Time to Death Cox regression test N=13 shorter survival N=5 longer survival N=8
AGE Spearman correlation test N=41 older N=15 younger N=26
PATHOLOGY T STAGE Spearman correlation test   N=0        
PATHOLOGY N STAGE Wilcoxon test N=1 class1 N=1 class0 N=0
PATHOLOGY M STAGE Kruskal-Wallis test   N=0        
HISTOLOGICAL TYPE Kruskal-Wallis test N=1908        
RADIATIONS RADIATION REGIMENINDICATION Wilcoxon test   N=0        
NUMBERPACKYEARSSMOKED Spearman correlation test   N=0        
NUMBER OF LYMPH NODES Spearman correlation test N=2 higher number.of.lymph.nodes N=0 lower number.of.lymph.nodes N=2
RACE Kruskal-Wallis test N=2        
ETHNICITY Wilcoxon test   N=0        
WEIGHT_KG_AT_DIAGNOSIS Spearman correlation test N=5 higher weight_kg_at_diagnosis N=5 lower weight_kg_at_diagnosis N=0
TUMOR_STATUS Wilcoxon test   N=0        
TUMOR_SAMPLE_PROCUREMENT_COUNTRY Kruskal-Wallis test   N=0        
NEOPLASMHISTOLOGICGRADE Kruskal-Wallis test N=4        
TOBACCO_SMOKING_YEAR_STOPPED Spearman correlation test   N=0        
TOBACCO_SMOKING_PACK_YEARS_SMOKED Spearman correlation test   N=0        
TOBACCO_SMOKING_HISTORY Kruskal-Wallis test N=1        
PATIENT AGEBEGANSMOKINGINYEARS Spearman correlation test   N=0        
RADIATION_TOTAL_DOSE Spearman correlation test   N=0        
RADIATION_THERAPY_TYPE Kruskal-Wallis test   N=0        
RADIATION_THERAPY_STATUS Wilcoxon test   N=0        
RADIATION_THERAPY_SITE Kruskal-Wallis test   N=0        
RADIATION_ADJUVANT_UNITS Wilcoxon test   N=0        
PREGNANCIES_COUNT_TOTAL Spearman correlation test   N=0        
PREGNANCIES_COUNT_STILLBIRTH Spearman correlation test   N=0        
PATIENT PATIENTPREGNANCYSPONTANEOUSABORTIONCOUNT Spearman correlation test   N=0        
PREGNANCIES_COUNT_LIVE_BIRTH Spearman correlation test   N=0        
PATIENT PATIENTPREGNANCYTHERAPEUTICABORTIONCOUNT Spearman correlation test   N=0        
PREGNANCIES_COUNT_ECTOPIC Spearman correlation test   N=0        
POS_LYMPH_NODE_LOCATION Kruskal-Wallis test   N=0        
MENOPAUSE_STATUS Kruskal-Wallis test N=4        
LYMPHOVASCULAR_INVOLVEMENT Wilcoxon test   N=0        
LYMPH_NODES_EXAMINED_HE_COUNT Spearman correlation test N=2 higher lymph_nodes_examined_he_count N=0 lower lymph_nodes_examined_he_count N=2
LYMPH_NODES_EXAMINED Spearman correlation test   N=0        
KERATINIZATION_SQUAMOUS_CELL Wilcoxon test N=1 non-keratinizing squamous cell carcinoma N=1 keratinizing squamous cell carcinoma N=0
INITIAL_PATHOLOGIC_DX_YEAR Spearman correlation test N=1 higher initial_pathologic_dx_year N=1 lower initial_pathologic_dx_year N=0
HISTORY_HORMONAL_CONTRACEPTIVES_USE Kruskal-Wallis test   N=0        
HEIGHT_CM_AT_DIAGNOSIS Spearman correlation test   N=0        
CORPUS_INVOLVEMENT Wilcoxon test   N=0        
CHEMO_CONCURRENT_TYPE Kruskal-Wallis test   N=0        
CERVIX_SUV_RESULTS Spearman correlation test N=7 higher cervix_suv_results N=4 lower cervix_suv_results N=3
AJCC_TUMOR_PATHOLOGIC_PT Kruskal-Wallis test N=1        
AGE_AT_DIAGNOSIS Spearman correlation test N=38 higher age_at_diagnosis N=13 lower age_at_diagnosis N=25
STAGE_EVENT CLINICAL_STAGE Kruskal-Wallis test   N=0        
Clinical variable #1: 'Time to Death'

13 genes related to 'Time to Death'.

Table S1.  Basic characteristics of clinical feature: 'Time to Death'

Time to Death Duration (Months) 0-195.8 (median=15.9)
  censored N = 183
  death N = 51
     
  Significant markers N = 13
  associated with shorter survival 5
  associated with longer survival 8
List of top 10 genes differentially expressed by 'Time to Death'

Table S2.  Get Full Table List of top 10 genes significantly associated with 'Time to Death' by Cox regression test

HazardRatio Wald_P Q C_index
TM2D1|83941 2.4 3.406e-08 0.00062 0.623
GATS|352954 0.53 7.138e-08 0.0013 0.26
ZER1|10444 0.17 4.925e-07 0.009 0.31
EGLN1|54583 2.8 6.313e-07 0.011 0.708
PEAR1|375033 1.62 1.485e-06 0.027 0.715
UBAC1|10422 0.24 4.825e-06 0.088 0.326
RIBC2|26150 0.74 6.89e-06 0.13 0.303
FAM95B1|100133036 0.75 1.065e-05 0.19 0.309
MATN3|4148 1.28 1.125e-05 0.2 0.693
ITGA5|3678 1.5 1.158e-05 0.21 0.678
Clinical variable #2: 'AGE'

41 genes related to 'AGE'.

Table S3.  Basic characteristics of clinical feature: 'AGE'

AGE Mean (SD) 47.19 (13)
  Significant markers N = 41
  pos. correlated 15
  neg. correlated 26
List of top 10 genes differentially expressed by 'AGE'

Table S4.  Get Full Table List of top 10 genes significantly correlated to 'AGE' by Spearman correlation test

SpearmanCorr corrP Q
NXNL2|158046 -0.4105 2.865e-10 5.21e-06
RHOF|54509 -0.3212 4.866e-07 0.00885
LANCL1|10314 0.3201 5.352e-07 0.00974
RARB|5915 0.3195 5.607e-07 0.0102
DBI|1622 0.3157 7.811e-07 0.0142
LHFPL1|340596 0.3642 9.04e-07 0.0164
GPR97|222487 -0.3136 9.267e-07 0.0169
HSFX2|100130086 0.3122 1.046e-06 0.019
UBASH3B|84959 -0.3097 1.287e-06 0.0234
PGR|5241 -0.3065 1.768e-06 0.0321
Clinical variable #3: 'PATHOLOGY.T.STAGE'

No gene related to 'PATHOLOGY.T.STAGE'.

Table S5.  Basic characteristics of clinical feature: 'PATHOLOGY.T.STAGE'

PATHOLOGY.T.STAGE Mean (SD) 1.4 (0.66)
  N
  1 123
  2 47
  3 8
  4 3
     
  Significant markers N = 0
Clinical variable #4: 'PATHOLOGY.N.STAGE'

One gene related to 'PATHOLOGY.N.STAGE'.

Table S6.  Basic characteristics of clinical feature: 'PATHOLOGY.N.STAGE'

PATHOLOGY.N.STAGE Labels N
  class0 112
  class1 49
     
  Significant markers N = 1
  Higher in class1 1
  Higher in class0 0
List of one gene differentially expressed by 'PATHOLOGY.N.STAGE'

Table S7.  Get Full Table List of one gene differentially expressed by 'PATHOLOGY.N.STAGE'

W(pos if higher in 'class1') wilcoxontestP Q AUC
ART3|419 995 2.791e-06 0.0508 0.7537
Clinical variable #5: 'PATHOLOGY.M.STAGE'

No gene related to 'PATHOLOGY.M.STAGE'.

Table S8.  Basic characteristics of clinical feature: 'PATHOLOGY.M.STAGE'

PATHOLOGY.M.STAGE Labels N
  M0 96
  M1 8
  MX 88
     
  Significant markers N = 0
Clinical variable #6: 'HISTOLOGICAL.TYPE'

1908 genes related to 'HISTOLOGICAL.TYPE'.

Table S9.  Basic characteristics of clinical feature: 'HISTOLOGICAL.TYPE'

HISTOLOGICAL.TYPE Labels N
  ADENOSQUAMOUS 4
  CERVICAL SQUAMOUS CELL CARCINOMA 200
  ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE 5
  ENDOCERVICAL TYPE OF ADENOCARCINOMA 22
  ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX 2
  MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE 6
     
  Significant markers N = 1908
List of top 10 genes differentially expressed by 'HISTOLOGICAL.TYPE'

Table S10.  Get Full Table List of top 10 genes differentially expressed by 'HISTOLOGICAL.TYPE'

ANOVA_P Q
EPCAM|4072 4.376e-17 7.96e-13
TP63|8626 4.516e-17 8.22e-13
GPR109A|338442 5.078e-17 9.24e-13
BICD2|23299 7.959e-17 1.45e-12
GM2A|2760 1.345e-16 2.45e-12
DDAH1|23576 1.851e-16 3.37e-12
GPR109B|8843 2.906e-16 5.29e-12
C3ORF54|389119 3.508e-16 6.38e-12
CLDN3|1365 3.865e-16 7.03e-12
PPP1R9A|55607 4.769e-16 8.67e-12
Clinical variable #7: 'RADIATIONS.RADIATION.REGIMENINDICATION'

No gene related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.

Table S11.  Basic characteristics of clinical feature: 'RADIATIONS.RADIATION.REGIMENINDICATION'

RADIATIONS.RADIATION.REGIMENINDICATION Labels N
  NO 33
  YES 206
     
  Significant markers N = 0
Clinical variable #8: 'NUMBERPACKYEARSSMOKED'

No gene related to 'NUMBERPACKYEARSSMOKED'.

Table S12.  Basic characteristics of clinical feature: 'NUMBERPACKYEARSSMOKED'

NUMBERPACKYEARSSMOKED Mean (SD) 18.37 (13)
  Significant markers N = 0
Clinical variable #9: 'NUMBER.OF.LYMPH.NODES'

2 genes related to 'NUMBER.OF.LYMPH.NODES'.

Table S13.  Basic characteristics of clinical feature: 'NUMBER.OF.LYMPH.NODES'

NUMBER.OF.LYMPH.NODES Mean (SD) 1 (2.4)
  Significant markers N = 2
  pos. correlated 0
  neg. correlated 2
List of 2 genes differentially expressed by 'NUMBER.OF.LYMPH.NODES'

Table S14.  Get Full Table List of 2 genes significantly correlated to 'NUMBER.OF.LYMPH.NODES' by Spearman correlation test

SpearmanCorr corrP Q
CD99L2|83692 -0.3622 1.18e-05 0.215
ART3|419 -0.383 1.334e-05 0.243
Clinical variable #10: 'RACE'

2 genes related to 'RACE'.

Table S15.  Basic characteristics of clinical feature: 'RACE'

RACE Labels N
  AMERICAN INDIAN OR ALASKA NATIVE 7
  ASIAN 18
  BLACK OR AFRICAN AMERICAN 26
  NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER 1
  WHITE 170
     
  Significant markers N = 2
List of 2 genes differentially expressed by 'RACE'

Table S16.  Get Full Table List of 2 genes differentially expressed by 'RACE'

ANOVA_P Q
XKR9|389668 1.445e-06 0.0263
RNF112|7732 1.005e-05 0.183
Clinical variable #11: 'ETHNICITY'

No gene related to 'ETHNICITY'.

Table S17.  Basic characteristics of clinical feature: 'ETHNICITY'

ETHNICITY Labels N
  HISPANIC OR LATINO 17
  NOT HISPANIC OR LATINO 151
     
  Significant markers N = 0
Clinical variable #12: 'WEIGHT_KG_AT_DIAGNOSIS'

5 genes related to 'WEIGHT_KG_AT_DIAGNOSIS'.

Table S18.  Basic characteristics of clinical feature: 'WEIGHT_KG_AT_DIAGNOSIS'

WEIGHT_KG_AT_DIAGNOSIS Mean (SD) 74.9 (22)
  Significant markers N = 5
  pos. correlated 5
  neg. correlated 0
List of 5 genes differentially expressed by 'WEIGHT_KG_AT_DIAGNOSIS'

Table S19.  Get Full Table List of 5 genes significantly correlated to 'WEIGHT_KG_AT_DIAGNOSIS' by Spearman correlation test

SpearmanCorr corrP Q
HCG26|352961 0.3222 1.24e-06 0.0226
AGER|177 0.3196 1.53e-06 0.0278
NUBP1|4682 0.3091 3.46e-06 0.063
AKAP5|9495 0.2986 7.635e-06 0.139
BLOC1S1|2647 0.2917 1.26e-05 0.229
Clinical variable #13: 'TUMOR_STATUS'

No gene related to 'TUMOR_STATUS'.

Table S20.  Basic characteristics of clinical feature: 'TUMOR_STATUS'

TUMOR_STATUS Labels N
  TUMOR FREE 74
  WITH TUMOR 26
     
  Significant markers N = 0
Clinical variable #14: 'TUMOR_SAMPLE_PROCUREMENT_COUNTRY'

No gene related to 'TUMOR_SAMPLE_PROCUREMENT_COUNTRY'.

Table S21.  Basic characteristics of clinical feature: 'TUMOR_SAMPLE_PROCUREMENT_COUNTRY'

TUMOR_SAMPLE_PROCUREMENT_COUNTRY Labels N
  BRAZIL 20
  CANADA 5
  NIGERIA 1
  RUSSIA 11
  UKRAINE 7
  UNITED STATES 181
  VIETNAM 14
     
  Significant markers N = 0
Clinical variable #15: 'NEOPLASMHISTOLOGICGRADE'

4 genes related to 'NEOPLASMHISTOLOGICGRADE'.

Table S22.  Basic characteristics of clinical feature: 'NEOPLASMHISTOLOGICGRADE'

NEOPLASMHISTOLOGICGRADE Labels N
  G1 15
  G2 110
  G3 96
  G4 1
  GX 14
     
  Significant markers N = 4
List of 4 genes differentially expressed by 'NEOPLASMHISTOLOGICGRADE'

Table S23.  Get Full Table List of 4 genes differentially expressed by 'NEOPLASMHISTOLOGICGRADE'

ANOVA_P Q
ABLIM1|3983 3.057e-06 0.0556
CDS1|1040 8.59e-06 0.156
FUT6|2528 9.671e-06 0.176
FUT2|2524 1.324e-05 0.241
Clinical variable #16: 'TOBACCO_SMOKING_YEAR_STOPPED'

No gene related to 'TOBACCO_SMOKING_YEAR_STOPPED'.

Table S24.  Basic characteristics of clinical feature: 'TOBACCO_SMOKING_YEAR_STOPPED'

TOBACCO_SMOKING_YEAR_STOPPED Mean (SD) 2000.41 (11)
  Significant markers N = 0
Clinical variable #17: 'TOBACCO_SMOKING_PACK_YEARS_SMOKED'

No gene related to 'TOBACCO_SMOKING_PACK_YEARS_SMOKED'.

Table S25.  Basic characteristics of clinical feature: 'TOBACCO_SMOKING_PACK_YEARS_SMOKED'

TOBACCO_SMOKING_PACK_YEARS_SMOKED Mean (SD) 18.37 (13)
  Significant markers N = 0
Clinical variable #18: 'TOBACCO_SMOKING_HISTORY'

One gene related to 'TOBACCO_SMOKING_HISTORY'.

Table S26.  Basic characteristics of clinical feature: 'TOBACCO_SMOKING_HISTORY'

TOBACCO_SMOKING_HISTORY Labels N
  CURRENT REFORMED SMOKER FOR < OR = 15 YEARS 33
  CURRENT REFORMED SMOKER FOR > 15 YEARS 8
  CURRENT REFORMED SMOKER, DURATION NOT SPECIFIED 3
  CURRENT SMOKER 52
  LIFELONG NON-SMOKER 106
     
  Significant markers N = 1
List of one gene differentially expressed by 'TOBACCO_SMOKING_HISTORY'

Table S27.  Get Full Table List of one gene differentially expressed by 'TOBACCO_SMOKING_HISTORY'

ANOVA_P Q
GPR15|2838 7.275e-07 0.0132
Clinical variable #19: 'PATIENT.AGEBEGANSMOKINGINYEARS'

No gene related to 'PATIENT.AGEBEGANSMOKINGINYEARS'.

Table S28.  Basic characteristics of clinical feature: 'PATIENT.AGEBEGANSMOKINGINYEARS'

PATIENT.AGEBEGANSMOKINGINYEARS Mean (SD) 21.48 (7.9)
  Significant markers N = 0
Clinical variable #20: 'RADIATION_TOTAL_DOSE'

No gene related to 'RADIATION_TOTAL_DOSE'.

Table S29.  Basic characteristics of clinical feature: 'RADIATION_TOTAL_DOSE'

RADIATION_TOTAL_DOSE Mean (SD) 3950.73 (1600)
  Significant markers N = 0
Clinical variable #21: 'RADIATION_THERAPY_TYPE'

No gene related to 'RADIATION_THERAPY_TYPE'.

Table S30.  Basic characteristics of clinical feature: 'RADIATION_THERAPY_TYPE'

RADIATION_THERAPY_TYPE Labels N
  COMBINATION 19
  EXTERNAL 72
  EXTERNAL BEAM 15
  INTERNAL 11
     
  Significant markers N = 0
Clinical variable #22: 'RADIATION_THERAPY_STATUS'

No gene related to 'RADIATION_THERAPY_STATUS'.

Table S31.  Basic characteristics of clinical feature: 'RADIATION_THERAPY_STATUS'

RADIATION_THERAPY_STATUS Labels N
  COMPLETED AS PLANNED 28
  TREATMENT NOT COMPLETED 3
     
  Significant markers N = 0
Clinical variable #23: 'RADIATION_THERAPY_SITE'

No gene related to 'RADIATION_THERAPY_SITE'.

Table S32.  Basic characteristics of clinical feature: 'RADIATION_THERAPY_SITE'

RADIATION_THERAPY_SITE Labels N
  DISTANT RECURRENCE 2
  LOCAL RECURRENCE 2
  PRIMARY TUMOR FIELD 28
  REGIONAL SITE 13
     
  Significant markers N = 0
Clinical variable #24: 'RADIATION_ADJUVANT_UNITS'

No gene related to 'RADIATION_ADJUVANT_UNITS'.

Table S33.  Basic characteristics of clinical feature: 'RADIATION_ADJUVANT_UNITS'

RADIATION_ADJUVANT_UNITS Labels N
  CGY 31
  GY 3
     
  Significant markers N = 0
Clinical variable #25: 'PREGNANCIES_COUNT_TOTAL'

No gene related to 'PREGNANCIES_COUNT_TOTAL'.

Table S34.  Basic characteristics of clinical feature: 'PREGNANCIES_COUNT_TOTAL'

PREGNANCIES_COUNT_TOTAL Mean (SD) 3.55 (2.5)
  Significant markers N = 0
Clinical variable #26: 'PREGNANCIES_COUNT_STILLBIRTH'

No gene related to 'PREGNANCIES_COUNT_STILLBIRTH'.

Table S35.  Basic characteristics of clinical feature: 'PREGNANCIES_COUNT_STILLBIRTH'

PREGNANCIES_COUNT_STILLBIRTH Mean (SD) 0.08 (0.36)
  Value N
  0 98
  1 5
  3 1
     
  Significant markers N = 0
Clinical variable #27: 'PATIENT.PATIENTPREGNANCYSPONTANEOUSABORTIONCOUNT'

No gene related to 'PATIENT.PATIENTPREGNANCYSPONTANEOUSABORTIONCOUNT'.

Table S36.  Basic characteristics of clinical feature: 'PATIENT.PATIENTPREGNANCYSPONTANEOUSABORTIONCOUNT'

PATIENT.PATIENTPREGNANCYSPONTANEOUSABORTIONCOUNT Mean (SD) 0.46 (0.83)
  Significant markers N = 0
Clinical variable #28: 'PREGNANCIES_COUNT_LIVE_BIRTH'

No gene related to 'PREGNANCIES_COUNT_LIVE_BIRTH'.

Table S37.  Basic characteristics of clinical feature: 'PREGNANCIES_COUNT_LIVE_BIRTH'

PREGNANCIES_COUNT_LIVE_BIRTH Mean (SD) 2.59 (1.8)
  Significant markers N = 0
Clinical variable #29: 'PATIENT.PATIENTPREGNANCYTHERAPEUTICABORTIONCOUNT'

No gene related to 'PATIENT.PATIENTPREGNANCYTHERAPEUTICABORTIONCOUNT'.

Table S38.  Basic characteristics of clinical feature: 'PATIENT.PATIENTPREGNANCYTHERAPEUTICABORTIONCOUNT'

PATIENT.PATIENTPREGNANCYTHERAPEUTICABORTIONCOUNT Mean (SD) 0.89 (1.9)
  Significant markers N = 0
Clinical variable #30: 'PREGNANCIES_COUNT_ECTOPIC'

No gene related to 'PREGNANCIES_COUNT_ECTOPIC'.

Table S39.  Basic characteristics of clinical feature: 'PREGNANCIES_COUNT_ECTOPIC'

PREGNANCIES_COUNT_ECTOPIC Mean (SD) 0.1 (0.34)
  Value N
  0 96
  1 9
  2 1
     
  Significant markers N = 0
Clinical variable #31: 'POS_LYMPH_NODE_LOCATION'

No gene related to 'POS_LYMPH_NODE_LOCATION'.

Table S40.  Basic characteristics of clinical feature: 'POS_LYMPH_NODE_LOCATION'

POS_LYMPH_NODE_LOCATION Labels N
  MACROSCOPIC PARAMETRIAL INVOLVEMENT 2
  MICROSCOPIC PARAMETRIAL INVOLVEMENT 6
  OTHER LOCATION, SPECIFY 32
  POSITIVE BLADDER MARGIN 1
  POSITIVE VAGINAL MARGIN 8
     
  Significant markers N = 0
Clinical variable #32: 'MENOPAUSE_STATUS'

4 genes related to 'MENOPAUSE_STATUS'.

Table S41.  Basic characteristics of clinical feature: 'MENOPAUSE_STATUS'

MENOPAUSE_STATUS Labels N
  INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) 2
  PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) 15
  POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) 65
  PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) 105
     
  Significant markers N = 4
List of 4 genes differentially expressed by 'MENOPAUSE_STATUS'

Table S42.  Get Full Table List of 4 genes differentially expressed by 'MENOPAUSE_STATUS'

ANOVA_P Q
SSBP3|23648 2.565e-06 0.0467
RARB|5915 6.525e-06 0.119
DBI|1622 8.399e-06 0.153
PRSS23|11098 1.112e-05 0.202
Clinical variable #33: 'LYMPHOVASCULAR_INVOLVEMENT'

No gene related to 'LYMPHOVASCULAR_INVOLVEMENT'.

Table S43.  Basic characteristics of clinical feature: 'LYMPHOVASCULAR_INVOLVEMENT'

LYMPHOVASCULAR_INVOLVEMENT Labels N
  ABSENT 67
  PRESENT 71
     
  Significant markers N = 0
Clinical variable #34: 'LYMPH_NODES_EXAMINED_HE_COUNT'

2 genes related to 'LYMPH_NODES_EXAMINED_HE_COUNT'.

Table S44.  Basic characteristics of clinical feature: 'LYMPH_NODES_EXAMINED_HE_COUNT'

LYMPH_NODES_EXAMINED_HE_COUNT Mean (SD) 1 (2.4)
  Significant markers N = 2
  pos. correlated 0
  neg. correlated 2
List of 2 genes differentially expressed by 'LYMPH_NODES_EXAMINED_HE_COUNT'

Table S45.  Get Full Table List of 2 genes significantly correlated to 'LYMPH_NODES_EXAMINED_HE_COUNT' by Spearman correlation test

SpearmanCorr corrP Q
CD99L2|83692 -0.3622 1.18e-05 0.215
ART3|419 -0.383 1.334e-05 0.243
Clinical variable #35: 'LYMPH_NODES_EXAMINED'

No gene related to 'LYMPH_NODES_EXAMINED'.

Table S46.  Basic characteristics of clinical feature: 'LYMPH_NODES_EXAMINED'

LYMPH_NODES_EXAMINED Mean (SD) 21.77 (12)
  Significant markers N = 0
Clinical variable #36: 'KERATINIZATION_SQUAMOUS_CELL'

One gene related to 'KERATINIZATION_SQUAMOUS_CELL'.

Table S47.  Basic characteristics of clinical feature: 'KERATINIZATION_SQUAMOUS_CELL'

KERATINIZATION_SQUAMOUS_CELL Labels N
  KERATINIZING SQUAMOUS CELL CARCINOMA 48
  NON-KERATINIZING SQUAMOUS CELL CARCINOMA 94
     
  Significant markers N = 1
  Higher in NON-KERATINIZING SQUAMOUS CELL CARCINOMA 1
  Higher in KERATINIZING SQUAMOUS CELL CARCINOMA 0
List of one gene differentially expressed by 'KERATINIZATION_SQUAMOUS_CELL'

Table S48.  Get Full Table List of one gene differentially expressed by 'KERATINIZATION_SQUAMOUS_CELL'

W(pos if higher in 'NON-KERATINIZING SQUAMOUS CELL CARCINOMA') wilcoxontestP Q AUC
QKI|9444 1084 4.368e-07 0.00795 0.7598
Clinical variable #37: 'INITIAL_PATHOLOGIC_DX_YEAR'

One gene related to 'INITIAL_PATHOLOGIC_DX_YEAR'.

Table S49.  Basic characteristics of clinical feature: 'INITIAL_PATHOLOGIC_DX_YEAR'

INITIAL_PATHOLOGIC_DX_YEAR Mean (SD) 2007.73 (5)
  Significant markers N = 1
  pos. correlated 1
  neg. correlated 0
List of one gene differentially expressed by 'INITIAL_PATHOLOGIC_DX_YEAR'

Table S50.  Get Full Table List of one gene significantly correlated to 'INITIAL_PATHOLOGIC_DX_YEAR' by Spearman correlation test

SpearmanCorr corrP Q
C9ORF171|389799 0.3893 9.346e-06 0.17
Clinical variable #38: 'HISTORY_HORMONAL_CONTRACEPTIVES_USE'

No gene related to 'HISTORY_HORMONAL_CONTRACEPTIVES_USE'.

Table S51.  Basic characteristics of clinical feature: 'HISTORY_HORMONAL_CONTRACEPTIVES_USE'

HISTORY_HORMONAL_CONTRACEPTIVES_USE Labels N
  CURRENT USER 10
  FORMER USER 47
  NEVER USED 56
     
  Significant markers N = 0
Clinical variable #39: 'HEIGHT_CM_AT_DIAGNOSIS'

No gene related to 'HEIGHT_CM_AT_DIAGNOSIS'.

Table S52.  Basic characteristics of clinical feature: 'HEIGHT_CM_AT_DIAGNOSIS'

HEIGHT_CM_AT_DIAGNOSIS Mean (SD) 161.78 (6.7)
  Significant markers N = 0
Clinical variable #40: 'CORPUS_INVOLVEMENT'

No gene related to 'CORPUS_INVOLVEMENT'.

Table S53.  Basic characteristics of clinical feature: 'CORPUS_INVOLVEMENT'

CORPUS_INVOLVEMENT Labels N
  ABSENT 93
  PRESENT 16
     
  Significant markers N = 0
Clinical variable #41: 'CHEMO_CONCURRENT_TYPE'

No gene related to 'CHEMO_CONCURRENT_TYPE'.

Table S54.  Basic characteristics of clinical feature: 'CHEMO_CONCURRENT_TYPE'

CHEMO_CONCURRENT_TYPE Labels N
  CARBOPLATIN 2
  CISPLATIN 17
  OTHER 1
     
  Significant markers N = 0
Clinical variable #42: 'CERVIX_SUV_RESULTS'

7 genes related to 'CERVIX_SUV_RESULTS'.

Table S55.  Basic characteristics of clinical feature: 'CERVIX_SUV_RESULTS'

CERVIX_SUV_RESULTS Mean (SD) 12.43 (5.5)
  Significant markers N = 7
  pos. correlated 4
  neg. correlated 3
List of 7 genes differentially expressed by 'CERVIX_SUV_RESULTS'

Table S56.  Get Full Table List of 7 genes significantly correlated to 'CERVIX_SUV_RESULTS' by Spearman correlation test

SpearmanCorr corrP Q
C14ORF33|100129075 0.9066 0 0
C7ORF11|136647 0.956 0 0
ELFN2|114794 0.9231 0 0
GRK7|131890 -0.9273 0 0
HAMP|57817 -0.8956 0 0
MBD4|8930 -0.9341 0 0
PTPRR|5801 0.9161 0 0
Clinical variable #43: 'AJCC_TUMOR_PATHOLOGIC_PT'

One gene related to 'AJCC_TUMOR_PATHOLOGIC_PT'.

Table S57.  Basic characteristics of clinical feature: 'AJCC_TUMOR_PATHOLOGIC_PT'

AJCC_TUMOR_PATHOLOGIC_PT Labels N
  T1A 1
  T1A1 1
  T1B 32
  T1B1 64
  T1B2 25
  T2 4
  T2A 8
  T2A1 7
  T2A2 10
  T2B 18
  T3 1
  T3B 7
  T4 3
  TIS 1
  TX 15
     
  Significant markers N = 1
List of one gene differentially expressed by 'AJCC_TUMOR_PATHOLOGIC_PT'

Table S58.  Get Full Table List of one gene differentially expressed by 'AJCC_TUMOR_PATHOLOGIC_PT'

ANOVA_P Q
FBXL18|80028 3.373e-06 0.0614
Clinical variable #44: 'AGE_AT_DIAGNOSIS'

38 genes related to 'AGE_AT_DIAGNOSIS'.

Table S59.  Basic characteristics of clinical feature: 'AGE_AT_DIAGNOSIS'

AGE_AT_DIAGNOSIS Mean (SD) 47.32 (13)
  Significant markers N = 38
  pos. correlated 13
  neg. correlated 25
List of top 10 genes differentially expressed by 'AGE_AT_DIAGNOSIS'

Table S60.  Get Full Table List of top 10 genes significantly correlated to 'AGE_AT_DIAGNOSIS' by Spearman correlation test

SpearmanCorr corrP Q
NXNL2|158046 -0.4092 2.741e-10 4.99e-06
DBI|1622 0.3213 3.857e-07 0.00702
GPR97|222487 -0.3188 4.774e-07 0.00869
UBASH3B|84959 -0.3118 8.731e-07 0.0159
PGR|5241 -0.3122 8.871e-07 0.0161
RHOF|54509 -0.3113 9.101e-07 0.0166
LOC440356|440356 0.3281 9.75e-07 0.0177
C20ORF151|140893 0.3077 1.239e-06 0.0225
RARB|5915 0.3075 1.253e-06 0.0228
LHFPL1|340596 0.3564 1.293e-06 0.0235
Clinical variable #45: 'STAGE_EVENT.CLINICAL_STAGE'

No gene related to 'STAGE_EVENT.CLINICAL_STAGE'.

Table S61.  Basic characteristics of clinical feature: 'STAGE_EVENT.CLINICAL_STAGE'

STAGE_EVENT.CLINICAL_STAGE Labels N
  STAGE I 4
  STAGE IA 2
  STAGE IA1 1
  STAGE IA2 1
  STAGE IB 34
  STAGE IB1 67
  STAGE IB2 34
  STAGE II 4
  STAGE IIA 6
  STAGE IIA1 5
  STAGE IIA2 7
  STAGE IIB 23
  STAGE III 1
  STAGE IIIB 33
  STAGE IVA 4
  STAGE IVB 7
     
  Significant markers N = 0
Methods & Data
Input

  • Expresson data file = CESC-TP.uncv2.mRNAseq_RSEM_normalized_log2.txt

  • Clinical data file = CESC-TP.merged_data.txt

  • Number of patients = 239

  • Number of genes = 18197

  • Number of clinical features = 45

Survival analysis

For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels

Correlation analysis

For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R

Student's t-test analysis

For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R

ANOVA analysis

For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[1] Andersen and Gill, Cox's regression model for counting processes, a large sample study, Annals of Statistics 10(4):1100-1120 (1982)
[2] Spearman, C, The proof and measurement of association between two things, Amer. J. Psychol 15:72-101 (1904)
[3] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[4] Howell, D, Statistical Methods for Psychology. (5th ed.), Duxbury Press:324-5 (2002)
[5] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)
Copyright © 2015 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle